A pharmaceutical company has become concerned about potential product liability that may result from the mix-up of several of its prescription pain pills and over-the counter medicines. This story is worth paying attention to because the underlying facts could affect the healths of New York residents.

Novartis, the Swiss pharmaceutical company, operates a drug manufacturing plant in Nebraska. That plant was shut down last week as a result of numerous complaints that mistakes had been made with respect to several of the products made at the facility. Continue reading →